Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of...
Eli Lilly and Regeneron are among the first seven companies selected by the U.S. Food and Drug Administration for a new pilot program. This initiative aims to accelerate the review process for new manufacturing facilities, potentially speeding up drug development and production.…
Market Samachar is a news aggregator. This article was originally published by cnbc.com. Tap the button above to read the full story on their site.